<?xml version="1.0" encoding="UTF-8"?>
<p>Chiang et al.
 <sup>
  <xref rid="bibr144-2515690X20978394" ref-type="bibr">144</xref>,
  <xref rid="bibr143-2515690X20978394" ref-type="bibr">143</xref>
 </sup> tested aqueous extracts of Plantago major and Plantago asiatica against HSV-1 (strain KOS) and HSV-2 (strain 196) in BCC-1/KMC cells. Both P. asiatica (EC
 <sub>50</sub> = 1318 μg/ml and SI = 46.5)
 <sup>
  <xref rid="bibr143-2515690X20978394" ref-type="bibr">143</xref>
 </sup> and P. major (EC
 <sub>50</sub> = 843 μg/ml and SI = 2.2)
 <sup>
  <xref rid="bibr144-2515690X20978394" ref-type="bibr">144</xref>,
  <xref rid="bibr143-2515690X20978394" ref-type="bibr">143</xref>
 </sup> demonstrated antiviral activity against HSV-2, but neither extract was active against HSV-1. The authors described the observed antiviral activity as weak, therefore P. major and P. asiatica are likely poor candidates for further HSV research.
</p>
